HLS Therapeutics Inc. (TSX:HLS)

HLS Therapeutics Revenue

HLS Therapeutics had revenue of $14.67M USD in the quarter ending June 30, 2026, with 3.54% growth. This brings the company's revenue in the last twelve months to $56.24M, down -0.32% year-over-year. In the year 2025, HLS Therapeutics had annual revenue of $55.50M, down -1.98%.

• Revenue (ttm): $56.24M
• Revenue Growth: -0.32%
• P/S Ratio: 1.47
• Revenue / Employee: $661.68K
• Employees: 85
• Market Cap: 117.24M CAD

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	55.50M	-1.12M	-1.98%
Dec 31, 2024	56.62M	-6.46M	-10.23%
Dec 31, 2023	63.07M	1.61M	2.61%
Dec 31, 2022	61.47M	1.46M	2.43%
Dec 31, 2021	60.01M	3.90M	6.95%
Dec 31, 2020	56.11M	1.95M	3.60%
Dec 31, 2019	54.16M	-7.26M	-11.81%
Dec 31, 2018	61.42M	-13.67M	-18.20%
Dec 31, 2017	75.08M	21.05M	38.96%
Dec 31, 2016	54.03M	-	-

Data Source: Fiscal.ai Last updated: Aug 12, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 28, 2026

Data Sources Report a data error